These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 16900025)
21. Update on the management of acute graft-versus-host disease. Bolaños-Meade J Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179 [TBL] [Abstract][Full Text] [Related]
22. Ocular manifestations of graft versus host disease. Anderson NG; Regillo C Curr Opin Ophthalmol; 2004 Dec; 15(6):503-7. PubMed ID: 15523196 [TBL] [Abstract][Full Text] [Related]
23. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Chiang CC; Lin JM; Chen WL; Tsai YY Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623 [TBL] [Abstract][Full Text] [Related]
24. Late effects of chronic graft-versus-host disease. Carpenter PA Best Pract Res Clin Haematol; 2008 Jun; 21(2):309-31. PubMed ID: 18503995 [TBL] [Abstract][Full Text] [Related]
25. How can we help patients with refractory chronic graft versus host disease- single centre experience. Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373 [TBL] [Abstract][Full Text] [Related]
26. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500 [TBL] [Abstract][Full Text] [Related]
27. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors. Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415 [TBL] [Abstract][Full Text] [Related]
38. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD. Blecha C; Wolff D; Holler B; Holler E; Weber D; Vogt R; Helbig H; Dietrich-Ntoukas T Ann Hematol; 2016 Feb; 95(3):493-9. PubMed ID: 26659079 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Rao SN; Rao RD Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659 [TBL] [Abstract][Full Text] [Related]